Page 14 - Company News

Ajanta Pharma sets aside ₹1K crore for acquisitions to plug therapy gaps

Pain management, dermatology, nephrology and gynaecology are emerging as key focus areas

Delhi HC allows Sun Pharma to export semaglutide, restricts sale in India

The Delhi High Court has allowed Sun Pharma to manufacture and export semaglutide-based drugs to countries where Novo Nordisk holds no patent, but barred sales in India until March 2026

IndiGo board to hire external specialist to trace root cause of disruption

IndiGo chairman Vikram Singh Mehta dismissed allegations that IndiGo engineered the crisis, tried to influence the government's flight duty time limitation (FDTL) rules

IndiGo trims Q3 capacity, revenue forecast after flight cancellations

The budget airline had scrapped at least 2,000 services last week because of poor pilot roster planning, leaving tens of thousands of passengers stranded

JSW Paints completes majority buy in Akzo Nobel India; stake at 61.2%

JSW Paints has completed the acquisition of 60.76% in Akzo Nobel India from Akzo Nobel N.V. and affiliates, taking its holding to 61.2% after buying an additional 0.44% via an open offer

TCS signs pact to buy Coastal Cloud for $700 million in all-cash deal

Tata Consultancy Services has signed an agreement to buy 100% of Coastal Cloud for $700 million in cash, adding 400+ Salesforce professionals and strengthening its advisory

Uber expands into B2B logistics, adds metro ticketing in Bengaluru via ONDC

Uber has entered B2B logistics in Bengaluru through Uber Direct, integrated Namma Metro ticketing on its app, both powered by ONDC, as it builds multi-service mobility and commerce offerings in India

Brookfield India Reit raises ₹3,500 cr via QIP to fund expansion plans

The Reit's manager has approved the allotment of about 10.93 crore units to successful eligible institutional investors at an issue price of ₹320 per unit

SBI raises data centre exposure target to Rs 4,000 crore for FY26

SBI plans to lift data centre exposure to Rs 4,000 crore by March 2026 from Rs 2,800 crore in October 2025, while setting up specialist teams and reviewing margins amid NIM contraction

Delaware court reverses $1 billion judgment against Byju Raveendran

Court agreed that damages had not been determined and ordered a new phase to commence in early January 2026 to determine any damages related to claims against Raveendran

Vedanta to invest ₹1 trn in Rajasthan to double production: Anil Agarwal

Vedanta Chairman Anil Agarwal said the latest investment will be used for the establishment of a zinc park to boost small and medium zinc manufacturing industries in the state

Transition VC closes oversubscribed ₹700 crore debut fund at final close

Backed by strategic LPs, Transition VC says its debut fund has crossed target to close at ₹700 crore, with early portfolio traction and plans under way for a second fund

DGCA summons IndiGo CEO; court raps govt, airline over crisis: Top points

On Wednesday, IndiGo cancelled over 60 flights from Bengaluru airport, even as CEO Pieter Elbers claimed yesterday that the airline's operations were back on track

Uber enters B2B logistics via ONDC, expands metro ticketing to Bengaluru

Uber's tie-up with ONDC brings its B2B logistics service, Uber Direct, to Bengaluru, beginning with grocery deliveries. The platform has also added metro ticket booking in the city

Sumadhura Group inks ₹600 cr pact with T'gana to develop 100-acre project

Signed at the Telangana Rising Global Summit 2025, held at Bharat Future City, the commitment aligns with the state's vision to transform Telangana into a $3 trillion economy

Thrilled about upcoming data centre capacity in India: Microsoft CEO

Earlier on Tuesday, Satya Nadella met with Prime Minister Narendra Modi, and shortly after that, he announced $17.5 bn investment in the country

Zydus Lifesciences introduces biosimilar for cancer patients' bone health

This will provide access and treat patients with bone metastases due to breast, prostate, lung, myeloma, kidney, thyroid and other solid tumours, the drug firm said in a regulatory filing

Adani Group to invest up to ₹12 trillion in India by 2031: Gautam Adani

The sizeable investments will be made in infrastructure, mining, renewable energy and ports, among others, he said

Delhi HC allows Sun Pharma to manufacture, export its weight loss drug

The approval marks a major win for Sun Pharma in its patent dispute with Danish drugmaker Novo Nordisk, the company that manufactures weight loss drug Ozempic

Meesho debuts on NSE, BSE; Prosus to hold 11.2% stake after listing

Prosus keeps an 11.2% stake after the closely watched listing, adding to a string of Indian tech IPOs